The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression

Abroad (travel likely)RecruitingPHASE3

Conditions

Myopia · Myopia Progression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Hefei Maternal and Child Health Hospital, Hefei, Anhui, China

    Contact: Study coordinator (Ruqin Zha)
  • The Second Hospital of Anhui Medical University, Hefei, Anhui, China

    Contact: Study coordinator (Liming Tao)
  • Xuancheng People's Hospital, Xuancheng, Anhui, China

    Contact: Study coordinator (Shenghua Dong)
  • The Second Hospital of Lanzhou University, Lanzhou, Gansu, China

    Contact: Study coordinator (Wanna Ren)
  • Liuzhou People's Hospital, Liuzhou, Guangxi, China

    Contact: Study coordinator (Xiaobo Wan)
  • The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China

    Contact: Study coordinator (Qi Chen)
  • The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

    Contact: Study coordinator (Hao Gu)
  • The First People's Hospital of Zunyi, Zunyi, Guizhou, China

    Contact: Study coordinator (Wei Tan)
  • Daqingshi People's Hospital, Daqing, Heilongjiang, China

    Contact: Study coordinator (Xingmin Wang)
  • Kaifeng Central Hospital, Kaifeng, Henan, China

    Contact: Study coordinator (Hongmei Mu)
  • The First Affiliated Hospital of University of South China, Hengyang, Hunan, China

    Contact: Study coordinator (Gang Tan)
  • Huai'an First People's Hospital, Huai'an, Jiangsu, China

    Contact: Study coordinator (Chaopeng Li)
  • Affiliated Eye Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Hongfei Liao)
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Xiaorong Wu)
  • The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Xiaolong Yin)
  • Weifang Eye Hospital, Weifang, Shandong, China

    Contact: Study coordinator (Xianyong Sun)
  • Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China

    Contact: Study coordinator (Yun Cui)
  • Shanxi Eye Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Junhong Li)
  • Xianyang Hospital of Yan'an University, Xianyang, Shanxi, China

    Contact: Study coordinator (Binke Yu)
  • Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Lijun Shen)
  • Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China

    Contact: Study coordinator (Feng Wu) · bjtrec@126.com · 0086-15910961255
    Contact: Study coordinator (Ningli Wang, Postdoctoral)
  • Peking University Third Hospital, Beijing, China

    Contact: Study coordinator (Yueguo Chen)
  • Chongqing Aier Eye Hospital, Chongqing, China

    Contact: Study coordinator (Yi Ren)
  • Shanghai Eye Disease Prevention and Treatment Center (Shanghai Eye Hospital), Shanghai, China

    Contact: Study coordinator (Haidong Zou)
    Contact: Study coordinator (Wei Xu)
  • Tianjin Medical University Eye Hospital, Tianjin, China

    Contact: Study coordinator (Lin Liu)
Study leads
  • Ningli Wang, Postdoctoral

    Principal Investigator

    Beijing Tongren Hospital Affiliated to Capital Medical University